Byline |
N Tohyama1 *, S Hashimoto2,3 , Y Fujita3 , t minemura4 , M Kurooka5 , Y Kumazaki6 , T Kawachi1 , T Kojima1 , T Kodama1 , K Hatano1 , S Ishikura7 , H Saitoh3 , (1) Chiba Cancer Center, Chiba, JP, (2) Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Tokyo, JP, (3) Tokyo Metropolitan University, Tokyo, JP, (4) National Cancer Center, Tokyo, JP, (5) Kanagawa Cancer Center, Kanagawa, JP, (6) Saitama Medical University, Saitama, JP, (7) Nagoya City University, Aichi, JP,
|